About this trial
In this prospective, randomized, controlled, double-blinded study, we aimed to evaluate the effects of Dextrose Prolotherapy injections in patients with coccydynia.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients with coccydynia lasting longer than 6 months,
Those unresponsive to at least 6 months of conventional conservative treatment methods,
Those with coccygeal tenderness on palpation,
Patients aged between 18 and 65 years.
Disqualifiers
Patients with a history of trauma within the last 3 months or postpartum coccydynia,
Those with lesions or infections at the injection site,
Those with dislocation or organic bone pathology of the coccyx observed on X-ray imaging,
Those with fecal or urinary incontinence,
Trial design
Parallel
Treatments tested in this trial
Dextrose prolotherapy (DPT)
Procedure/SurgeryCoccyx injection: Using a sterile 27-gauge syringe (dental needle), a total of 10 cc of solution (5 cc of 30% dextrose + 4 cc of physiological saline + 1 cc of 1% lidocaine solution) will be injected perpendicularly to the surface at the previously marked attachment points of the sacrococcygeal-sacro-tuberous ligaments to the sacrum and along the entire coccyx.
Physiological Saline Injection
Procedure/SurgerySaline + lidocaine group injection protocol: Using a sterile 30-gauge syringe (insulin needle), a total of 10 cc of solution (5 cc of physiological saline + 5 cc of 1% lidocaine solution) will be injected into the previously marked tendon attachment points on the bone.
Treatment groups
Trial outcomes
Primary outcomes
Visual Analog Scale
Pain intensity during sitting and activity
Secondary outcomes
Paris Functional Coccydynia Questionnaire
Functional status assessment
Visual Analog Scale-Global Assesment
Daily living activities and patient global assessment
Sponsors and contacts
Click on the lead sponsor to view all of their trials.